EXPLOSIVE: Secret Interview Exposes Pfizer

Leave a CommentEXPLOSIVE: Secret Interview Exposes PfizerANews, MedTech, Video

Pfizer Exposed For Exploring “Mutating” COVID-19 Virus For New Vaccines Via ‘Directed Evolution’

Project Veritas released a new video today exposing a Pfizer executive, Jordon Trishton Walker, who claims that his company is exploring a way to “mutate” COVID via “Directed Evolution” to preemptively develop future vaccines.

Walker says that Directed Evolution is different than Gain-of-Function, which is defined as “a mutation that confers new or enhanced activity on a protein.” In other words, it means that a virus such as COVID can become more potent depending on the mutation / scientific experiment performed on it.

Here are some of the highlights from today’s video:

  • Jordon Trishton Walker, Pfizer Director of Research and Development, Strategic Operations – mRNA Scientific Planner: “One of the things we’re exploring is like, why don’t we just mutate it [COVID] ourselves so we could create — preemptively develop new vaccines, right? So, we have to do that. If we’re gonna do that though, there’s a risk of like, as you could imagine — no one wants to be having a pharma company mutating f**king viruses.”
  • Walker: “Don’t tell anyone. Promise you won’t tell anyone. The way it [the experiment] would work is that we put the virus in monkeys, and we successively cause them to keep infecting each other, and we collect serial samples from them.”
  • Walker: “You have to be very controlled to make sure that this virus [COVID] that you mutate doesn’t create something that just goes everywhere. Which, I suspect, is the way that the virus started in Wuhan, to be honest. It makes no sense that this virus popped out of nowhere. It’s bullsh*t.”
  • Walker: “From what I’ve heard is they [Pfizer scientists] are optimizing it [COVID mutation process], but they’re going slow because everyone is very cautious — obviously they don’t want to accelerate it too much. I think they are also just trying to do it as an exploratory thing because you obviously don’t want to advertise that you are figuring out future mutations.”